METHYLPHENIDATE (Tuzulby®) prolonged-release chewable tablets
Clinical Indication
ADHD
Date of classification
June 2026
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.